NRF2 Metagene Expression Associated with Worse Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer

被引：1
|
作者：
O'Cathail, S. M. [1 ]
Chieh, W. H. [2 ]
Maughan, T. S. [3 ]
Hawkins, M. A. [1 ]
机构：
[1] Univ Oxford, CRUK MRC Oxford Inst Radiat Oncol, Oxford, England
[2] Dept Stat, Oxford, England
[3] CRUK MRC Oxford Inst Radiat Oncol, Oxford, England
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.177
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1097
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [1] Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
    Zhang, Yiyi
    Yan, Liangliang
    Wu, Yong
    Xu, Meifang
    Liu, Xing
    Guan, Guoxian
    [J]. BMC CANCER, 2020, 20 (01)
  • [2] Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
    Yiyi Zhang
    Liangliang Yan
    Yong Wu
    Meifang Xu
    Xing Liu
    Guoxian Guan
    [J]. BMC Cancer, 20
  • [3] MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
    Svoboda, Marek
    Sana, Jiri
    Fabian, Pavel
    Kocakova, Ilona
    Gombosova, Jana
    Nekvindova, Jana
    Radova, Lenka
    Vyzula, Rostislav
    Slaby, Ondrej
    [J]. RADIATION ONCOLOGY, 2012, 7
  • [4] MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
    Marek Svoboda
    Jiri Sana
    Pavel Fabian
    Ilona Kocakova
    Jana Gombosova
    Jana Nekvindova
    Lenka Radova
    Rostislav Vyzula
    Ondrej Slaby
    [J]. Radiation Oncology, 7
  • [5] Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer
    Akiyoshi, T.
    Tanaka, N.
    Kiyotani, K.
    Gotoh, O.
    Yamamoto, N.
    Oba, K.
    Fukunaga, Y.
    Ueno, M.
    Mori, S.
    [J]. BRITISH JOURNAL OF SURGERY, 2019, 106 (10) : 1381 - 1392
  • [6] NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer
    O'Cathail, Sean M.
    Wu, Chieh-Hsi
    Lewis, Annabelle
    Holmes, Chris
    Hawkins, Maria A.
    Maughan, Tim
    [J]. CANCER GENETICS, 2020, 248 : 1 - 10
  • [7] Is Metformin Associated With Improved Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer?
    Planellas, Pere
    Cornejo, Lidia
    Ignacio Rodriguez-Hermosa, Jose
    Maldonado, Eloy
    Timoteo, Ander
    Hernandez-Yague, Xavier
    Farres, Ramon
    Codina-Cazador, Antoni
    [J]. JOURNAL OF SURGICAL RESEARCH, 2021, 268 : 465 - 473
  • [8] Molecular predictors of response to neoadjuvant chemoradiotherapy in rectal cancer
    Fleischmann, Maximilian
    Diefenhardt, Markus
    Fokas, Emmanouil
    Roeder, Claus
    Roeder, Franz
    [J]. ONKOLOGE, 2022, 28 (02): : 118 - 125
  • [9] Rectal cancer: Neoadjuvant chemoradiotherapy
    Roedel, Claus
    Hofheinz, Ralf
    Fokas, Emmanouil
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2016, 30 (04) : 629 - 639
  • [10] STATIN THERAPY IS ASSOCIATED WITH IMPROVED PATHOLOGIC RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN RECTAL CANCER.
    Mace, A.
    Gantt, G.
    Kalady, M.
    [J]. DISEASES OF THE COLON & RECTUM, 2013, 56 (04) : E110 - E110
12345